Goldman Sachs’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.7M Sell
1,557,804
-12,247
-0.8% -$293K ﹤0.01% 1897
2025
Q4
$41.9M Sell
1,570,051
-532,399
-25% -$12.7M 0.01% 1661
2025
Q3
$44.9M Buy
2,102,450
+633,962
+43% +$15M 0.01% 1501
2025
Q2
$31.7M Sell
1,468,488
-710,282
-33% -$13.2M 0.01% 1705
2025
Q1
$36.2M Sell
2,178,770
-701,694
-24% -$12.7M 0.01% 1471
2024
Q4
$52.9M Buy
2,880,464
+1,121,605
+64% +$18.1M 0.01% 1244
2024
Q3
$27.1M Buy
1,758,859
+417,915
+31% +$6.97M 0.01% 1783
2024
Q2
$21.8M Buy
1,340,944
+613,039
+84% +$9.89M ﹤0.01% 1823
2024
Q1
$13.5M Sell
727,905
-76,265
-9% -$1.89M ﹤0.01% 2192
2023
Q4
$25.2M Buy
804,170
+85,545
+12% +$2.04M 0.01% 1692
2023
Q3
$15M Sell
718,625
-554,799
-44% -$15.1M ﹤0.01% 2034
2023
Q2
$30.5M Buy
1,273,424
+293,686
+30% +$6.53M 0.01% 1492
2023
Q1
$18.4M Sell
979,738
-10,885
-1% -$207K 0.01% 1880
2022
Q4
$15.8M Sell
990,623
-189,775
-16% -$2.97M ﹤0.01% 2168
2022
Q3
$19.3M Buy
1,180,398
+122,904
+12% +$1.99M 0.01% 1900
2022
Q2
$14.9M Sell
1,057,494
-46,883
-4% -$875K ﹤0.01% 2137
2022
Q1
$26.7M Sell
1,104,377
-77,546
-7% -$1.88M 0.01% 1815
2021
Q4
$27.6M Buy
1,181,923
+355,077
+43% +$7.14M 0.01% 1838
2021
Q3
$13.7M Buy
826,846
+265,531
+47% +$5.12M ﹤0.01% 2413
2021
Q2
$13.7M Sell
561,315
-480,934
-46% -$10.9M ﹤0.01% 2397
2021
Q1
$26.9M Buy
1,042,249
+31,159
+3% +$1.37M 0.01% 1682
2020
Q4
$54.1M Buy
1,011,090
+51,023
+5% +$2.53M 0.02% 1071
2020
Q3
$39.6M Sell
960,067
-140,479
-13% -$6.07M 0.01% 1178
2020
Q2
$53.3M Sell
1,100,546
-295,931
-21% -$14.2M 0.02% 905
2020
Q1
$59M Buy
1,396,477
+142,920
+11% +$5.89M 0.02% 760
2019
Q4
$53.6M Buy
1,253,557
+2,181
+0.2% +$94.9K 0.02% 1090
2019
Q3
$45M Sell
1,251,376
-377,611
-23% -$11.5M 0.01% 1177
2019
Q2
$43.5M Sell
1,628,987
-304,158
-16% -$7.77M 0.01% 1232
2019
Q1
$51.9M Sell
1,933,145
-418,767
-18% -$9.78M 0.02% 1093
2018
Q4
$38M Buy
2,351,912
+1,074,005
+84% +$20.9M 0.01% 1291
2018
Q3
$26.5M Buy
1,277,907
+535,024
+72% +$8.42M 0.01% 1711
2018
Q2
$11.3M Sell
742,883
-540,163
-42% -$9.63M ﹤0.01% 2306
2018
Q1
$28.8M Buy
1,283,046
+92,122
+8% +$2.55M 0.01% 1550
2017
Q4
$35.9M Sell
1,190,924
-629,354
-35% -$20.1M 0.01% 1522
2017
Q3
$68.6M Sell
1,820,278
-87,973
-5% -$2.86M 0.02% 1063
2017
Q2
$53.2M Buy
1,908,251
+785,352
+70% +$23.4M 0.02% 1192
2017
Q1
$38.6M Sell
1,122,899
-421,359
-27% -$14.9M 0.01% 1398
2016
Q4
$44.5M Buy
1,544,258
+365,067
+31% +$9.66M 0.02% 1356
2016
Q3
$37.5M Buy
1,179,191
+846,830
+255% +$28.7M 0.01% 1429
2016
Q2
$10.8M Buy
332,361
+28,093
+9% +$940K ﹤0.01% 2252
2016
Q1
$8.51M Buy
304,268
+181,489
+148% +$3.96M ﹤0.01% 2346
2015
Q4
$4.38M Buy
122,779
+34,292
+39% +$1.21M ﹤0.01% 2950
2015
Q3
$2.93M Buy
88,487
+60,201
+213% +$2.5M ﹤0.01% 3404
2015
Q2
$1.18M Sell
28,286
-21,696
-43% -$840K ﹤0.01% 4385
2015
Q1
$1.63M Buy
49,982
+9,970
+25% +$343K ﹤0.01% 3983
2014
Q4
$1.27M Sell
40,012
-191,213
-83% -$5.42M ﹤0.01% 4310
2014
Q3
$5.72M Sell
231,225
-169,022
-42% -$3.95M ﹤0.01% 2871
2014
Q2
$9.04M Buy
400,247
+102,567
+34% +$2.14M ﹤0.01% 2456
2014
Q1
$7.24M Sell
297,680
-201,850
-40% -$5.11M ﹤0.01% 2658
2013
Q4
$12.5M Buy
499,530
+25,953
+5% +$612K 0.01% 2169
2013
Q3
$13M Sell
473,577
-85,070
-15% -$1.78M 0.01% 1980
2013
Q2
$10.1M Buy
+558,647
New +$7.69M 0.01% 2079

Other funds holding ACAD